Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without serious bleeding episodes for at least a year, according to results published ...

FRIDAY, Dec. 12, 2025 (HealthDay News) — More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial ...

Google Labs today announced “Disco” as an experiment to “shape the future of web browsing.” The first flagship feature of this AI browser is the Gemini 3-powered “GenTab.” For Google, Disco is a ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...

Researchers are testing low-dose radiation to treat the painful symptoms of osteoarthritis in the knee. The study, published by researchers in Korea and presented at the American Society for Radiation ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

This useful study presents a real-time transcriptomics analysis, with the aim of providing rapid access to sequenced data to reduce the costs associated with Oxford Nanopore long-read technology. The ...

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. In what experts are calling a “dream come true,” scientists used a recent biochemical discovery ...

Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...

An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the company that developed the shot. However, it is still early days. When you ...